UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients

Breast cancer research : BCR, 2018-10, Vol.20 (1), p.120-120, Article 120

2018

Volltextzugriff (PDF)

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

Clinical cancer research, 2022-11, Vol.28 (21), p.4714-4723

2022

Volltextzugriff (PDF)

Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

Clinical cancer research, 2008-10, Vol.14 (19), p.6330-6335

2008

Volltextzugriff (PDF)

Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer

JAMA oncology, 2022-11, Vol.8 (11), p.1579

2022

Volltextzugriff (PDF)

Intratumoral Estrogen Disposition in Breast Cancer

Clinical cancer research, 2010-03, Vol.16 (6), p.1790-1801

2010

Volltextzugriff (PDF)

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

BMC cancer, 2017-02, Vol.17 (1), p.97, Article 97

2017

Volltextzugriff (PDF)

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer

Breast cancer research : BCR, 2012-03, Vol.14 (2), p.R47-R47, Article R47

2012

Volltextzugriff (PDF)

Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation

Clinical cancer research, 2011-08, Vol.17 (15), p.4948-4958

2011

Volltextzugriff (PDF)

APOBEC3A/B deletion polymorphism and endometrial cancer risk

Cancer medicine (Malden, MA), 2023-03, Vol.12 (6), p.6659-6667

2023

Volltextzugriff (PDF)

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

PloS one, 2012-06, Vol.7 (6), p.e38364

2012

Volltextzugriff (PDF)

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

European journal of cancer (1990), 2012-09, Vol.48 (13), p.1988-1996

2012

Volltextzugriff (PDF)

Long-Term Follow-Up of the Intergroup Exemestane Study

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2507-2514

2017

Volltextzugriff (PDF)

Vascular proliferation is a prognostic factor in breast cancer

Breast cancer research and treatment, 2012-06, Vol.133 (2), p.501-510

2012

Volltextzugriff (PDF)

Assessment of tumor suppressor promoter methylation in healthy individuals

Clinical epigenetics, 2020-08, Vol.12 (1), p.131-131, Article 131

2020

Volltextzugriff (PDF)

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate

Oncotarget, 2016-05, Vol.7 (19), p.28637-28646

2016

Volltextzugriff (PDF)

Mutation of GATA3 in human breast tumors

Oncogene, 2004-10, Vol.23 (46), p.7669-7678

2004

Volltextzugriff (PDF)

Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer

JCO precision oncology, 2023-09, Vol.7 (7), p.e2300338

2023

Volltextzugriff (PDF)

Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon

International journal of cancer, 2015-07, Vol.137 (1), p.96-103

2015

Volltextzugriff (PDF)

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

Clinical cancer research, 2009-06, Vol.15 (12), p.4165-4173

2009

Volltextzugriff (PDF)

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Breast cancer research and treatment, 2001-05, Vol.67 (2), p.111-116

2001

Volltextzugriff (PDF)

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Volltextzugriff (PDF)

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

Genes chromosomes & cancer, 2006-11, Vol.45 (11), p.1033-1040

2006

Volltextzugriff (PDF)

Interpreting plasma estrogen levels in breast cancer: caution needed

Journal of clinical oncology, 2014-05, Vol.32 (14), p.1396-1400

2014

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(118)

Sprache

Englisch
(118)

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Life Sciences & Biomedicine
(115)
Humans
(106)
Female
(95)
Breast Neoplasms - Drug Therapy
(61)
Biological And Medical Sciences
(42)
Medical Sciences
(42)
Breast Cancer
(40)
Middle Aged
(40)
Aged
(36)
Breast Neoplasms - Genetics
(32)
Tumors
(30)
Antineoplastic Agents
(28)
Pharmacology. Drug Treatments
(28)
Breast Neoplasms - Pathology
(23)
Adult
(22)
Mutation
(22)
Chemotherapy
(21)
Antineoplastic Agents - Therapeutic Use
(20)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients

Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers

Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer

Intratumoral Estrogen Disposition in Breast Cancer

MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer

Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation

APOBEC3A/B deletion polymorphism and endometrial cancer risk

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

Long-Term Follow-Up of the Intergroup Exemestane Study

Vascular proliferation is a prognostic factor in breast cancer

Assessment of tumor suppressor promoter methylation in healthy individuals

Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate

Mutation of GATA3 in human breast tumors

Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer

Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon

A Mitochondrial Target Sequence Polymorphism in Manganese Superoxide Dismutase Predicts Inferior Survival in Breast Cancer Patients Treated with Cyclophosphamide

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

Interpreting plasma estrogen levels in breast cancer: caution needed

Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)

Aktive Filter

Suchergebnisse filtern